• Keine Ergebnisse gefunden

Supplementary Figure S6:

N/A
N/A
Protected

Academic year: 2022

Aktie "Supplementary Figure S6:"

Copied!
3
0
0

Wird geladen.... (Jetzt Volltext ansehen)

Volltext

(1)

Supplementary Figure S6: Multiple protein sequence alignment for B-cell-lymphoma protein 2 (Bcl-2)-associated X (BAX) inhibitor (BI) proteins (BI) and Lifeguard 4-like (LFG4) orthologs.

A) Alignment of orthologs for the putative BI-1 encoded by the transcript DIAVI026079 that is differentially expressed between Gpp34/Tpp35Ab1 exposed and unexposed D. v. virgifera (Dvv) larvae. Accession provided for Anoplophora glabripennis (AG), Dendroctonus ponderosae (Dp), Drosophila melanogaster (Dm), Leptinotarsa decemlineata (Ld), and Tribolium

castaneum (Tc). Isoforms are designated as A or B following accessions for Dm. Residues with 100% conservation are highlighted dark grey and those ≥50% are in light grey. Transmembrane regions are double underlined for corresponding regions annotated within D. melanogaster UniProt record Q9VSH3 and putative TMRs from DIAVI026079 predicted by TMHMM 2.0.

DIAVI026079 --MATEYVRFSPNAFLNSFNAKLEQPVRQHLKNVYACLAMST MS AA L G AAV HLFT NIMQA 58 XP_028141533.1_Dvv --MATEYVRFSPNAFLNSFNAKLEQPVRQHLKNVYACLAMSTMSAALGAAVHLFTNIMQA 58 XP_971485.1_Tc ---MAPSVQTFLNSFSNSLEAPVRQHLKNVYACLAMSTMAAAIGASIHLFTNIIQA 53 XP_018561952.1_Ag ---MAAPSVQTFLNSFNNKLEEPVRQHLKNVYACLAMSTMAVAIGASVHIFTDFLQA 54 XP_023023598.1_Ld ---MAAASVQTFLNSFDAKLEQPVRAHLKNVYACLAMSTMAAAVGASVHLFTNILQA 54 XP_019762956.1_Dp ---MASVGINNFINSFNNRLEPPVKQHLKNVYACLAMSTLAAGVGGSIHLFTNLLQA 54 ERL83674.1_Dp_Hyp ---MSTLAAGVGGSIHLFTNLLQA 21 NP_648205.1_DmA MADTANYINDRFQTFMNGLGDRYEPYVREHL SK VY MV L GSTAA A T A M G AML Q-MRDF L DL 59 NP_729358.1_DMB MADTANYINDRFQTFMNGLGDRYEPYVREHL SK VY MV L GSTAA A T A M G AML Q-MRDF L DL 59 DIAVI026079 G FLSAIGAL V FFF L L VN TPDDNGKSMTTRV G Y L LG F TF LT G VG L GPLL EHVI LVEPS II I 118 XP_028141533.1_Dvv GFLSAIGALVFFFLLVNTPDDNGKSMTTRVGYLLGFTFLTGVGLGPLLEHVILVEPSIII 118 XP_971485.1_Tc GFLSGIGALIFFGLLMATPDDNGKGLKMRIGYLLGFTTLTGVGMGPLLEHVIAVDPSIIV 113 XP_018561952.1_Ag GFLSAIGALVFFFLLMSTPDNNGKGLTLRVGYLLGFTFLTGVGMGPLLDFVIMVDPSIIV 114 XP_023023598.1_Ld GFISAIGALVCFYLLMSTPDDNGKAMTKRVGYLLGFSGLTGVGMGPLLEHVILVNPTIIV 114 XP_019762956.1_Dp GFLSGIGAIIFFFLLISTPDDNGKGMMKRVGYLLGFATLTGVGMGPLLEHVILVNPSIII 114 ERL83674.1_Dp_HyP GFLSGIGAIIFFFLLISTPDDNGKGMMKRVGYLLGFATLTGVGMGPLLEHVILVNPSIII 81 NP_648205.1_DmA G V L A A VAT L VLV -L GLHF YKDDGKNYYTRLG M L YA F GFCS G QTL GPLL GYI CSINPAII L 118 NP_729358.1_DMB G V L A A VAT L VLV -L GLHF YKDDGKNYYTRLG M L YA F GFCS G QTL GPLL GYI CSINPAII L 118 DIAVI026079 T A FV A T S T V F VSF S AASM L SERGRWLYLGG T L M TM L TT LM V L S LA N IF FGAMWIYQT Q L Y 178 XP_028141533.1_Dvv TAFVATSTVFVSFSAASMLSERGRWLYLGGTLMTMLTTLMVLSLANIFFGAMWIYQTQLY 178 XP_971485.1_Tc TALIGTAVVFVSFSVCSLLAERGKWLYLGGTLMSLLSTLMILSLANLFFGSSMLFQIQLY 173 XP_019762956.1_Dp TAFIATSVVFVSFSICAIFSERGKWLYLGGTLFTLLNSLMLMSLANILFGSTLLWNIQIY 174 ERL83674.1_Dp_HypP TAFIATSVVFVSFSICAIFSERGKWLYLGGTLFTLLNSLMLMSLANILFGSTLLWNIQIY 141 XP_023023598.1_Ld TAFFATSAVFVCFSICAMLSERGKWLYLGGTLMSMLTALMVLSFANLFFGAVWIYQTQLY 174 XP_018561952.1_Ag TAFIGTSAVFLCFSICALLSERGKWLYLGGTLMSIITILMLLSLANIFFGAMWVYQAQLY 174 NP_648205.1_DmA S A LTG T F V T F ISL S LS A L LAEQGKY LYLGG M L V S VINTMAL L S L F NMVFKSYFVQVT Q L Y 178 NP_729358.1_DMB S A LTG T F V T F ISL S LS A L LAEQGKY LYLGG M L V S VINTMAL L S L F NMVFKSYFVQVT Q L Y 178 DIAVI026079 L G L L A M CG F VLY DTQMIIEKRRLGSRDFVAHSLDLFVDFIGIFRRLLVILTQREQEAQRK 238 XP_028141533.1_Dvv LGLLAMCGFVLYDTQMIIEKRRLGSRDFVAHSLDLFVDFIGIFRRLLVILTQREQEAQRK 238 XP_971485.1_Tc LGLFAMCGFVLYDTQLIIEKRRLGSKDFVTHSLDLFVDFIGIFRRVLIILTQKEQESQKK 233 XP_019762956.1_Dp LGLFAMCGFVLYDTQAIIEKRRMGSKDFVAHSLDLFVDFIGVFKRLLIILTQKEQDQKKK 234 ERL83674.1_Dp_HypP LGLFAMCGFVLYDTQAIIEKRRMGSKDFVAHSLDLFVDFIGVFKRLLIILTQKEQDQKKK 201 XP_023023598.1_Ld LGLLAMCGFVLFDTQMIIEKRRAGSRDFVAHSLDLFVDFIGIFRRLLIILTQKEQDSRKK 234 XP_018561952.1_Ag VGLLAMCGFVLYDTQVIVEKRRMGSKDFVGHSLDLFIDFIGIFKRLLIILTQKEQNSRKK 234 NP_648205.1_DmA V G V F V M AA F IV Y DTQNIVEKCRNGNRDVVQHALDLFFDVLSMFRRLLIILTQKEERKQNE 238 NP_729358.1_DMB V G V F V M AA F IV Y DTQNIVEKCRNGNRDVVQHALDLFFDVLSMFRRLLIILTQKLKTFMV- 237 DIAVI026079 KRRD*-- 242

XP_028141533.1_Dvv KRRD--- 242 XP_971485.1_Tc RRN---- 236 XP_019762956.1_Dp KGNN--- 238 ERL83674.1_Dp_HypP KGNN--- 205 XP_023023598.1_Ld RRD---- 237 XP_018561952.1_Ag RRN---- 237

(2)

NP_648205.1_DmA RRQNKTK 245 NP_729358.1_DMB --- 237

B) Alignment of orthologs for the putative LFG4 encoded by the transcript DIAVI029891 that is differentially expressed among Cry3Bb1 and Gpp34/Tpp35Ab1 exposed D. v. virgifera (Dvv) larvae compared to non-exposed cohorts. Isoforms are designated as A, B, C or D following accessions for Dm. Residues with 100% conservation are highlighted dark grey and those

≥50% are in light grey. Helical domains double underlined determined for D. v. virgifera proteins using TMHMM 2.0, and retrieved from Uniprot records for the orthologs from D.

melanogaster (Dm; NP_610824.1 isoform A: Q6AWP0; NP_725236.1 isoform B: Q8T8W2;

NP_001260927.1 isoform C), and T. castaneum (Tc; XP_969476.1: D6WLJ9). Abbreviations for species associated with corresponding accessions are provided above.

DIAVI029891_Dvv ---MSQTVSLILNEDVEHGGKEYDE 22 XP_028155171.1_Dvv ---MSQTVSLILNEDVEHGGKEYDE 22 XP_969476.1_Tc ---MSSTVPLILEEDCERGGKDFDE 22 XP_018567206.1_Ag ---MSQTIPLILEEDVEQGGKEYDE 22 XP_023024494.1_Lc ---MSQTVPLILQEDIEQGGKEYED 22 XP_019762126.1_Dp MKDIYFEVSYNLGKHLLKFLWSKQSQFISIKVCEQEIKMSQSVPLILTEDVERGGKEYEE 60 NP_610824.1_DmA ---MSSDNHFQYD 10 NP_725236.1_DmB ---MYHYQQGDETGAYTD 15 NP_001260927.1_DmC --- 0 NP_001260928.1_DmD ---MSSDNHFQYD 10

DIAVI029891_Dvv DDIENDFAYRNNVLNATKQIRLAFIRKVY GL L S M Q I LL T F II A SICL F T PPIKSFVHTND 82 XP_028155171.1_Dvv DDIENDFAYRNNVLNATKQIRLAFIRKVY GL L S M Q I LL T F II A SICL F T PPIKSFVHTND 82 XP_969476.1_Tc EGIENDFAYRNNVMQASKTIRLGFIRKVY GL L S M Q L LL T IVV A SIFM F T PQIKTFVHEND 82 XP_018567206.1_Ag -DIENDFAYRNNVAQATKSIRMAFIRKVYGLLTMQIFLTIVIASICMFTPPIKDFVHSND 81 XP_023024494.1_Lc -EIENDFAYRNNVWQATKSIRLAFIRKVYGLLTMQIFLTIVIAAVCMFTPPIRSFVQSND 81 XP_019762126.1_Dp NDIENDFAYRNNVAQATKSIRLAFLRKVYGLLTMQILLTVTIAAIFMFTPPIKVFVQTND 120 NP_610824.1_DmA AEADKSFAF---DDQSIRKGFIRKVY LI L MC Q L L I T F GFVSVFT F S KASQEWVQKNP 64 NP_725236.1_DmB AEADKSFAF---DDQSIRKGFIRKVY LI L MC Q L L I T F GFVSVFT F S KASQEWVQKNP 69 NP_001260927.1_DmC ---MCQLLITFGFVSVFTFSKASQEWVQKNP 28 NP_001260928.1_DmD AEADKSFAF---DDQSIRKGFIRKVY LI L MC Q L L I T F GFVSVFT F S KASQEWVQKNP 64

DIAVI029891_Dvv ---W MMMFS F IA SI A LL VP L HI KRKESPT N F I L L IA FT VV Q AYT I G VIVT F YSKVV VL Q A 139 XP_028155171.1_Dvv ---W MMMFS F IA SI A LL VP L HI KRKESPT N F I L L IA FT VV Q AYT I G VIVT F YSKVV VL Q A 139 XP_969476.1_Tc ---W MLLVS F IP SI F LL IA L II KRRDTPA N L I L L AA FT VV E AYT V G VILT Y Y SQAVVL Q A 139 XP_018567206.1_Ag ---WILMPTFLGSIALLLALHIKRRESPTNLILLAAFTIVQAYTIGVIVTFYSQAVVLQA 138 XP_023024494.1_Lc ---WMMLVTFFGSIALLLALHVKRRESPANFILLTAFTVVQAYTIGVIVTFYSQAVVLQA 138 XP_019762126.1_Dp ---WMMMISFFASIILLIPLHIKRRESPTNLILLAAFTIVQAYTIGVIVTFYSKAIVLEA 177 NP_610824.1_DmA ALF W IALAVLIVTMICMACC ESVRRKTPLNFI F L FL FT V AESFLL G MVAGQF EADEVL M A 124 NP_725236.1_DmB ALF W IALAVLIVTMICMACC ESVRRKTPLNFI F L FL FT V AESFLL G MVAGQF EADEVL M A 129 NP_001260927.1_DmC ALF W IALAVLIVTMICMACC ESVRRKTPLNFI F L FL FT V AESFLL G MVAGQF EADEVL M A 88 NP_001260928.1_DmD ALF W IALAVLIVTMICMACC ESVRRKTPLNFI F L FL FT V AESFLL G MVAGQF EADEVL M A 124

DIAVI029891_Dvv L V L T LVVLVA LT AF TF QTKRDFSA TH S A L F A G L C IL I V G G FM Q I F I QSSIL EL G I GLG GA 199 XP_028155171.1_Dvv L V L T LVVLVA LT AF TF QTKRDFSA TH S A L F A G L C IL I V G G FM Q I F I QSSIL EL G I GLG GA 199 XP_969476.1_Tc L L L T LVIVGS LT FY TF QTKRDFSAMYSG L F A G L G IL I V G G FL Q I F FH SSTFEIV I SLG GA 199 XP_018567206.1_Ag LLLTFVVLAGLTLYTFQTKRDFSAIHSALFAGLCILIIGGFMQVFLQSTIFEIAIGFSGA 198 XP_023024494.1_Lc LLLTLVVLGGLTLYTFQTKRDFSAMHSGLFAGLIILIIGGSMQAFLQSSILEIAISLGGA 198 XP_019762126.1_Dp LLLTLLVLGGLTIYTFQSKHDFSAMHSGLFAGLLILIVGGFIQVFIQSPIFELLIGFGGA 237 NP_610824.1_DmA VGI T AAVAL G LT LFAL QTKYDFTMCGGV L V A C L VVF I IF G IIAI F I PGKVIG LV YASL GA 184 NP_725236.1_DmB VGI T AAVAL G LT LFAL QTKYDFTMCGGV L V A C L VVF I IF G IIAI F I PGKVIG L VYASL GA 189

(3)

NP_001260927.1_DmC VGI T AAVAL G LT LFAL QTKYDFTMCGGV L V A C L VVF I IF G IIAI F I PGKVIG L VYASL GA 148 NP_001260928.1_DmD VGI T AAVAL G LT LFAL QTKYDFTMCGGV L V A C L VVF I IF G IIAI F I PGKVIG L VYASL GA 184

DIAVI029891_Dvv F L F C LFI VV DTQMIMK---TLSPEEYI L A TI NLY M DI I N L F V YIL R I L QELNRQ* 250 XP_028155171.1_Dvv F L F C LFI VV DTQMIMK---TLSPEEYI L A TI NLY M DI I N L F V YIL R I L QELNRQ- 250 XP_969476.1_Tc F L F C LFI IF D T QMMMQ---TLSAEEYI L A TI NLY L DI I N L F L YIL R I L QAMNRQ- 250 XP_018567206.1_Ag LVFSLFIIFDTQLIMK---TLSPEEYILATINLYMDIVNLFLYILRILQAVNRQ- 249 XP_023024494.1_Lc LVFCLFIIFDTQMIMK---TLSPEEYILATINLYMDIINLFIYILRILQELNRN- 249 XP_019762126.1_Dp FLFCLFIIYDSKLIME---TLSPEEYILATINLYMDIINLFIYILRILQALNRQ- 288 NP_610824.1_DmA LL F SVYLV Y DTQLMLGGNHKYSISPEEYI F A AL NLY L DI I N I F M YIL T I IGL SRN-- 239 NP_725236.1_DmB LL F SVYLV Y DTQLMLGGNHKYSISPEEYI F A AL NLY L DI I N I F M YIL T I IGL SRN-- 244 NP_001260927.1_DmC LL F SVYLV Y DTQLMLGGNHKYSISPEEYI F A AL NLY L DI I N I F M YIL T I IGL SRN-- 203 NP_001260928.1_DmD LL F SVYLV Y DTQLMLGGNHKYSISPEEYI F A AL NLY L DI I N I F M YIL T I IGL SRN-- 239

Referenzen

ÄHNLICHE DOKUMENTE

Supplementary Figure S3: Gene Ontology (GO) terms enriched among transcripts differentially expressed in Heterorhabditis bacteriophora (Hb) and Metarhizium anisopliae (Ma)

DRONC NRRRIGAEKDSKSLIHLFQELNFTI-FP---YGNVNQDQFFKLLTMVTSSSYVQNTECFVMVLMTHGNSV 56 XP_028140498.1 FPYRNGALVDDANLKALFEQMGGWDLDC---YHNKTALEMIMLIQKFAG-EGKPDYDICCMIIMSHGGEM

Two baculovirus inhibition of apoptosis protein repeat domains (BIR1 and BIR2) and RING finder domains characteristic of IAP family 1 proteins are underlined, and cysteine

Nuclear size estimation of PC3 xenograft sections. Nuclear size assessment

BSCs plot obtained from an in vivo prostate tumour model pre-and-post 24 hours after USMB and HT treatment.. A representative plot of the measured BSC and its best- fit

*Underlines indicate the restriction enzyme sites. Supplementary

HeLa cells were exposed to etop 200 nM, campto 20 nM or MMC 100 nM for 24 h or 8 h, and analyzed by immunofluorescence microscopy with antibodies directed against H2AX and

Supplementary Figure 1c: Conceptual model for factors contributing to medication adherence in adults with chronic, non-communicable conditions with asymptomatic